Liberalizing Requirements for Hospital Proximity Post-CD19 CAR for Children with Low Burden B-ALL at Infusion
Lauren Appell(University of Arkansas Medical Center), Liora M. Schultz(Stanford Medicine), Holly Pacenta(Children's Hospital Colorado), Erin Hall(Children's Mercy Hospital), Michael R. Verneris(NHS Blood and Transplant), Christa Krupski(Cincinnati Children's Hospital Medical Center), Sunil S. Raikar(Emory University), Kevin O. McNerney(Children's Hospital of Philadelphia), Samuel John(Southwestern Medical Center), Gary Douglas Myers(Baylor College of Medicine), Vanessa A. Fabrizio(Children's Hospital Colorado), Muna Qayed(Emory University), Danielle Novetsky Friedman(National Coalition for Cancer Survivorship), Lena E. Winestone(University of California, San Francisco), Prakash Satwani(Pediatrics and Genetics), Christina Baggott(Palo Alto University), Stacy Cooper(Sidney Kimmel Comprehensive Cancer Center), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Amy K. Keating(Boston Children's Hospital), Susanne H.C. Baumeister(Dana-Farber Cancer Institute), Snehit Prabhu(Stanford University), Jenna Rossoff(Lurie Children's Hospital), Nicole Karras(City Of Hope National Medical Center), Amy Moskop(Medical College of Wisconsin), Julie‐An Talano(Dana-Farber Cancer Institute), Theodore W. Laetsch(Children's Hospital of Philadelphia), Crystal L. Mackall(Parker Institute for Cancer Immunotherapy), Arunkumar Modi(University of Iowa), Khanh Nguyen(Stanford University), Rachel Phelan(Children's Hospital of Wisconsin), Heather Emily Stefanski(University of Minnesota), Christine L. Phillips(Cincinnati Children's Hospital Medical Center), Michelle L. Hermiston(VinUniversity)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795